Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Byrd

Showing results (131-140 of 188) with videos related to

Pageof 19
Sort By:
Cancer Research|February 1, 1991
Relationship of pancreatic cancer apomucin to mammary and intestinal apomucinsJ C Byrd, J J Ho, D T Lamport, et al.
Blood|August 10, 1999
Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cellsJ C Byrd, C Shinn, R Ravi, et al.
The Journal of Clinical Investigation|March 1, 1991
Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasisR S Bresalier, Y Niv, J C Byrd, et al.
Blood|August 15, 1997
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)M R Baer, C C Stewart, D Lawrence, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
Molecular cloning of cDNAs derived from a novel human intestinal mucin geneJ R Gum, J W Hicks, D M Swallow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?C K Murray, E Estey, E Paietta, et al.
Seminars in Oncology|July 6, 2000
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disordersJ C Byrd, M R Grever, J K Waselenko, et al.
Analytical Biochemistry|March 1, 1988
Structural characterization of intact, branched oligosaccharides by high performance liquid chromatography and liquid secondary ion mass spectrometryJ W Webb, K Jiang, B L Gillece-Castro, et al.
Glycobiology|December 1, 1994
Alterations of O-glycan biosynthesis in human colon cancer tissuesJ M Yang, J C Byrd, B B Siddiki, et al.
Leukemia|December 13, 2005
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanismA P Mone, C Cheney, A L Banks, et al.
Pageof 19

Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
Cancer Research|February 1, 1991
Relationship of pancreatic cancer apomucin to mammary and intestinal apomucinsJ C Byrd, J J Ho, D T Lamport, et al.
Blood|August 10, 1999
Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cellsJ C Byrd, C Shinn, R Ravi, et al.
The Journal of Clinical Investigation|March 1, 1991
Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasisR S Bresalier, Y Niv, J C Byrd, et al.
Blood|August 15, 1997
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)M R Baer, C C Stewart, D Lawrence, et al.
Biochemical and Biophysical Research Communications|August 31, 1990
Molecular cloning of cDNAs derived from a novel human intestinal mucin geneJ R Gum, J W Hicks, D M Swallow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?C K Murray, E Estey, E Paietta, et al.
Seminars in Oncology|July 6, 2000
Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disordersJ C Byrd, M R Grever, J K Waselenko, et al.
Analytical Biochemistry|March 1, 1988
Structural characterization of intact, branched oligosaccharides by high performance liquid chromatography and liquid secondary ion mass spectrometryJ W Webb, K Jiang, B L Gillece-Castro, et al.
Glycobiology|December 1, 1994
Alterations of O-glycan biosynthesis in human colon cancer tissuesJ M Yang, J C Byrd, B B Siddiki, et al.
Leukemia|December 13, 2005
Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanismA P Mone, C Cheney, A L Banks, et al.
Pageof 19